Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents

Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents In the UK, the Pfizer/BioNTech is currently only approved for use to prevent COVID-19 in individuals aged 16 and over. ... In March, Pfizer and BioNTech revealed positive data for their vaccine in adolescents aged 12 to 15, both with or without prior

Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’

Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’ Pfizer has cautioned against removing intellectual property (IP) protections in a submission to an Australian parliamentary inquiry into vaccine fraud. ... Pfizer maintained that waiving IP protections “may invite copycat medicines from suppliers that

Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments

Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments In its first quarter results, Pfizer reported that the vaccine had already generated $3.5bn in global revenues. ... If Bourla is correct, it is safe to assume that Pfizer will continue to see significant growth for its COVID-19 vaccine over the next five

EU asks AZ to deliver 120 million COVID-19 vaccines by the end of June

EU asks AZ to deliver 120 million COVID-19 vaccines by the end of June Instead, the EU will likely rely on the Pfizer/BioNTech vaccine, after signing a new contract to receive 1.8 billion doses of the jab for 2021 to 2023.

Emergency authorisation for Pfizer/BioNTech vaccine expanded in the US

Emergency authorisation for Pfizer/BioNTech vaccine expanded in the US The new approval makes Pfizer/BioNTech’s COVID-19 vaccine the first to be authorised in the US for individuals in this age group. ... Pfizer and BioNTech have also submitted the data from this trial to a number of additional global regulators,

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...